EUVIMEDEUVIMED entdecken
Open Access

Therapeutic potential of trazodone in trigeminal neuralgia based on inflammation and oxidative stress: an in vitro experimental study

Jun Yang, Junling Huang, Zhimin Pan, Xiao Wang

Journal of Oral & Facial Pain and Headache · 2024

DOI: 10.22514/jofph.2024.020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oral & Facial Pain and Headache, 2024. Verfasst von Jun Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), 31…. Hauptthemen laut MEDLINE: Trazodone, Oxidative Stress, Trigeminal Neuralgia, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trigeminal neuralgia (TN) is a debilitating condition affecting the patients’ life quality. New therapeutic approaches and novel drugs are required to treat TN. Trazodone being a serotonin antagonist and reuptake inhibitor (SARI) provides neuroprotection, however its role and underlying mechanism in TN in vitro or in vivo are not clear. This study was aimed to investigate the trazodone impact on glial BV-2 cells regarding TN. It was found that trazodone inhibited the BV-2 cells growth and suppressed the inflammation and oxidative stress in Lipopolysaccharide (LPS)-treated BV-2 cells. Trazodone treatment specifically decreased the levels of Tumor Necrosis Factor-alpha (TNF-α), Interleukin-6 (IL-6), Interleukin-1 beta (IL-1β) (p < 0.05), and Reactive Oxygen Species (ROS) (p < 0.01). Moreover, trazodone suppressed the Mitogen-Activated Protein Kinase (MAPK) pathway in LPS-treated BV-2 cells. These outcomes demonstrate that trazodone suppressed glial cell hyperproliferation, inflammation, and oxidative stress through MAPK pathway activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrazodoneOxidative StressTrigeminal NeuralgiaInflammationSelective Serotonin Reuptake InhibitorsAnimalsMiceReactive Oxygen SpeciesLipopolysaccharidesCell LineInterleukin-1betaCell ProliferationTumor Necrosis Factor-alphaInterleukin-6Neuroglia

Stichwörter der Autor:innen

InflammationMAPK pathwayOxidative stressTrazodoneTrigeminal neuralgia (TN)

Substanzen

TrazodoneReactive Oxygen SpeciesLipopolysaccharidesSelective Serotonin Reuptake InhibitorsInterleukin-1betaTumor Necrosis Factor-alphaInterleukin-6

Autor:innen und Institutionen

  • Department of Geriatrics, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), 310003 Hangzhou, Zhejiang, China.
  • Department of Geriatrics, Tongji Hospital, School of Medicine Tongji University, 200065 Shanghai, China.

Zitieren

APA

Yang, J., Huang, J., Pan, Z., & Wang, X. (2024). Therapeutic potential of trazodone in trigeminal neuralgia based on inflammation and oxidative stress: an in vitro experimental study. Journal of Oral & Facial Pain and Headache. https://doi.org/10.22514/jofph.2024.020

Vancouver

Yang J, Huang J, Pan Z, Wang X. Therapeutic potential of trazodone in trigeminal neuralgia based on inflammation and oxidative stress: an in vitro experimental study. Journal of Oral & Facial Pain and Headache. 2024. doi:10.22514/jofph.2024.020

BibTeX
@article{Yang2024,
  author = {Yang, Jun and Huang, Junling and Pan, Zhimin and Wang, Xiao},
  title = {Therapeutic potential of trazodone in trigeminal neuralgia based on inflammation and oxidative stress: an in vitro experimental study},
  journal = {Journal of Oral & Facial Pain and Headache},
  year = {2024},
  doi = {10.22514/jofph.2024.020}
}
Kostenlos starten →